Related Experiment Video
Updated: Feb 12, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations
Yanzhuo Luo1,2, Bingjin Li3, Guangxin Zhang4
1Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, China.
Abstract:
Targeted therapies based on EGFR mutations or on the ALK fusion oncogene have become the standard treatment for certain patients with lung adenocarcinoma (LUAD). However, most LUAD patients have no EGFR mutation or ALK fusion, and their oncogenetic alterations remain to be characterized. Here we conducted an integrated analysis of public datasets to assess the genomic alterations of 23 highly lung cancer-associated genes. The copy numbers of these genes were measured in ten micro-dissected, paired tumors and normal lung tissues of LUAD patients without EGFR mutations or ALK fusion. The copy numbers of PTEN, RB1, HMGA2, and PTPRD were lower in tumors compared with those for normal tissues. Although there were reduced mRNA levels of PTEN and RB1 in tumors, there was a correlation between copy number and expression only for PTEN. In addition, analysis of the copy number alterations of these 23 genes revealed correlations between EMSY/CCND1, EMSY/PIK3CA, CCND1/CDKN2A, and CCND1/PIK3CA. Our exploration of integrated copy number and gene expression analysis gives priority to the PTEN-PIK3CA and RB1-CCND1 pathways in developing therapeutic strategies for LUAD patients without EGFR mutations or ALK fusion.
Insights
Most lung adenocarcinoma patients lack EGFR mutations or ALK fusions. This study identifies genomic alterations in these patients, highlighting PTEN-PIK3CA and RB1-CCND1 pathways for potential targeted therapies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Targeted therapies for EGFR mutations and ALK fusions are standard for some lung adenocarcinoma (LUAD) patients.
- Most LUAD patients lack these specific alterations, necessitating characterization of their oncogenetic landscape.
Purpose of the Study:
- To assess genomic alterations in 23 key lung cancer genes in LUAD patients without EGFR mutations or ALK fusions.
- To explore correlations between copy number and gene expression for therapeutic target identification.
Main Methods:
- Integrated analysis of public genomic datasets.
- Measurement of copy numbers for 23 cancer-associated genes in paired tumor and normal LUAD tissues.
- Analysis of gene expression and copy number alterations.
Main Results:
- Lower copy numbers of PTEN, RB1, HMGA2, and PTPRD observed in tumors versus normal tissues.
- Reduced mRNA levels for PTEN and RB1, with copy number-expression correlation only for PTEN.
- Identified correlations between EMSY/CCND1, EMSY/PIK3CA, CCND1/CDKN2A, and CCND1/PIK3CA.
Conclusions:
- The PTEN-PIK3CA and RB1-CCND1 pathways are prioritized for developing therapeutic strategies in LUAD patients lacking EGFR mutations or ALK fusions.
- Genomic profiling is crucial for identifying novel therapeutic targets in LUAD subtypes.
More Related Videos
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
What is Gene Expression?
Cell Specific Gene Expression
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

